Literature DB >> 7578168

Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.

M R Mehra1, H O Ventura, D D Stapleton, F W Smart, T C Collins, S R Ramee.   

Abstract

BACKGROUND: The clinical utility of intimal hyperplasia detected by intravascular ultrasonography in predicting cardiac events in heart transplant recipients with cardiac allograft vasculopathy has not been previously investigated.
METHODS: Intravascular ultrasonographic examination of 74 consecutive heart transplant recipients, including 62 men and 12 women with a mean age of 51 +/- 10 years (range 22 to 68 years), was performed at the time of annual angiography. Two groups of study patients were identified: group I consisted of patients with minimal, mild, or moderate intimal thickness by intravascular ultrasonography, whereas group II patients had severe intimal thickness.
RESULTS: Patient characteristics were similar in both groups except for higher serum triglycerides (220 +/- 95 versus 165 +/- 79 mg/dl), more advanced donor age (28 +/- 11 versus 23 +/- 6 years) and greater duration of follow-up after transplantation (3.3 +/- 1.4 versus 1.8 +/- 1.2 years) in group II patients with severe intimal thickening (p < 0.01). Cardiac events were defined as the occurrence of sudden death, myocardial infarction, or the need for coronary revascularization via percutaneous or surgical intervention. One cardiac event occurred in group I patients (sudden death), whereas seven events were noted in the group II patients (p = 0.006). Cardiac events in the group of patients with severe intimal thickening included four patients with sudden cardiac death and three patients who underwent percutaneous revascularization procedures involving directional coronary atherectomy. Angiograms were normal in 62% of patients who had cardiac events.
CONCLUSIONS: This study represents one of the first reports that provides evidence that severe intimal hyperplasia predicts the development of cardiac events even in the presence of a normal coronary angiogram.

Entities:  

Mesh:

Year:  1995        PMID: 7578168

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  24 in total

Review 1.  Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.

Authors:  Gregory A Payne; Fadi G Hage; Deepak Acharya
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

2.  Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.

Authors:  Travis B DeSa; Muhannad A Abbasi; Julie A Blaisdell; Kai Lin; Jeremy D Collins; James C Carr; Michael Markl
Journal:  Clin Imaging       Date:  2019-12-19       Impact factor: 1.605

Review 3.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

4.  Routine coronary angiography after heart transplantation.

Authors:  S C Grant; N H Brooks; R D Levy
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

5.  Should positron emission tomography be the standard of care for non-invasive surveillance following cardiac transplantation?

Authors:  Robert J H Miller; Jon A Kobashigawa; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2018-11-12       Impact factor: 5.952

6.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

Review 7.  Cardiac allograft vasculopathy: a review.

Authors:  Danny Ramzy; Vivek Rao; Julie Brahm; Santiago Miriuka; Diego Delgado; Heather J Ross
Journal:  Can J Surg       Date:  2005-08       Impact factor: 2.089

Review 8.  Management of allosensitized cardiac transplant candidates.

Authors:  Mauricio Velez; Maryl R Johnson
Journal:  Transplant Rev (Orlando)       Date:  2009-10       Impact factor: 3.943

9.  Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients.

Authors:  Ali Javaheri; Maria Molina; Payman Zamani; Amrith Rodrigues; Eric Novak; Susan Chambers; Patricia Stutman; Wilhelmina Maslanek; Mary Williams; Scott M Lilly; Peter Heeger; Mohamed H Sayegh; Anil Chandraker; David M Briscoe; Kevin P Daly; Randall Starling; David Ikle; Jason Christie; J Eduardo Rame; Lee R Goldberg; Jeffrey Billheimer; Daniel J Rader
Journal:  J Heart Lung Transplant       Date:  2016-07-15       Impact factor: 10.247

10.  Coronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy.

Authors:  Kory J Lavine; Marc Sintek; Eric Novak; Gregory Ewald; Edward Geltman; Susan Joseph; John Pfeifer; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2013-05-24       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.